Lord, Abbett & Co
OGN icon

Lord, Abbett & Co’s Organon & Co OGN Stock Holding History

Lord, Abbett & Co’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,028,350
Closed -$87.3M – 563
2023
Q3 		$87.3M Sell
5,028,350
-202,689
-4% -$4.23M 0.32% 89
2023
Q2 		$109M Sell
5,231,039
-1,391,416
-21% -$30.2M 0.37% 75
2023
Q1 		$156M Sell
6,622,455
-838,305
-11% -$22.5M 0.56% 31
2022
Q4 		$208M Sell
7,460,760
-710,177
-9% -$18.2M 0.74% 19
2022
Q3 		$191M Sell
8,170,937
-405,502
-5% -$12.2M 0.7% 22
2022
Q2 		$289M Buy
8,576,439
+481,549
+6% +$16.9M 1.02% 10
2022
Q1 		$283M Buy
8,094,890
+3,619,655
+81% +$124M 0.75% 19
2021
Q4 		$136M Buy
4,475,235
+1,349,077
+43% +$43.9M 0.31% 96
2021
Q3 		$103M Buy
3,126,158
+114,458
+4% +$3.66M 0.25% 124
2021
Q2 		$91.1M Buy
+3,011,700
New +$99.1M 0.22% 137

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Lord, Abbett & Co's OGN Position: Q4 2023 in Review

Lord, Abbett & Co sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 5,028,350 shares — an estimated $87.3M sold.

Lord, Abbett & Co first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $289M in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Lord, Abbett & Co reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 5,028,350 Organon & Co shares in Q4 2023, an estimated $87.3M.
  • Lord, Abbett & Co first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Lord, Abbett & Co's Organon & Co position peaked at $289M in Q2 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Lord, Abbett & Co's 13F filing for Q4 2023, filed 12 Feb 2024.